BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 1, 2001
View Archived Issues
New porcine cell line producing porcine endogenous retrovirus available for licensing from NIH
Read More
Superior side effect profile of tolterodine vs. oxybutynin in overactive bladder
Read More
First mglu1 receptor antagonist with inverse agonist activity discovered at Bayer
Read More
Hemagen Diagnostics completes development of unique HIV diagnostic test
Read More
Synthetic fragment of secreted human peptide inhibits IL-8-induced nasal inflammation
Read More
Patient enrollment begins in SCLC trial of TAP-derived antibody-based therapy
Read More
Luveris reaches first market following late November approval by European Commission
Read More
Recent data for SDZ-ASM-981 summarized at scientific meeting and in medical journal
Read More
Novartis obtains license to Dr. Reddy's novel insulin sensitizer
Read More
Rigel boosts IgE receptor regulation program for asthma/allergy
Read More
Wilex antibody receives orphan drug status for RCC from FDA
Read More
Graffinity and Aventis sign drug discovery alliance
Read More
Amylin submits MAA for Symlin in the E.U.
Read More
BIIL-284: a potent, orally active LTB4 antagonist with promise in inflammatory diseases
Read More
Tripos and Lipha drug discovery alliance makes progress
Read More
Alzheimer's disease drug candidate shows promise in the laboratory
Read More
Significant survival benefit associated with rhAPC in PROWESS trial
Read More
MediGene completes patient enrollment in phase III trial of Polyphenon E
Read More
Company Profile: Paratek
Read More
Rofecoxib and celecoxib safe for use in aspirin-sensitive asthmatics
Read More
Company Profile: Neuronyx
Read More
New neuraminidase inhibitors in the Abbott pipeline
Read More
Natural plant extracts useful for psoriasis according to Scottish researchers
Read More
Antiproliferative agents with an indoline structure designed at Boehringer Ingelheim
Read More
Substituted pyrroles synthesized by Roche particularly useful in solid tumor therapy
Read More
P&G patents new series of matrix metalloproteinase inhibitors and their use
Read More
SGLT2 inhibitors useful alone and in combination for Rx of diabetes and related disorders
Read More
Antioxidant metalloporphyrins in development by UAB for neurological diseases
Read More
